The venture capital team at Bristol-headquartered national law firm TLT has advised long-standing client Sussex Place Ventures on its part in a $10m (£7.53m) investment in healthcare tech firm Endomag.
London-based Sussex Place Ventures joined London and Cambridge-based tech-focused investor Draper Esprit on the C round funding, which Endomag will use to grow its global capabilities as it develops a patent-protectable technology to improve the standard of breast cancer care. 
The Cambridge-based firm, which spun out of University College London and University of Houston, has designed a unique clinical platform that uses magnetic fields to power diagnostic and therapeutic devices.
TLT previously advised Sussex Place when it led a £2m investment round in Endomagnetics, as it was known, in 2014.
The TLT team acting on the latest investment was led by corporate partner Jon Gill, supported by tax legal director Mark Braude and corporate associate Bryan Shaw.
Sussex Place operating partner John Brimacombe said: “Endomag is carving out an impressive position in healthcare solutions and we are delighted to continue to support their global expansion.
“TLT delivers the same high standards of service and communication on each deal we instruct them on, which is why we continue to use Jon and the team.”
Jon Gill, pictured, added: “The venture capital market continues to be very active, and we are seeing an increasing amount of capital flowing into healthcare technology ventures at present.
“We were delighted to support the Sussex Place Ventures team on this latest follow-on investment within their portfolio and wish Endomag and their wider stakeholders continued success in their global expansion.”
Earlier this year TLT advised Sussex Place on its second investment in Kimble Applications, one of the world’s leading professional services automation (PSA) providers.
